Pulse Biosciences Inc Common Stock (DE) (PLSE)
PLSE trades on Nasdaq in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1625101/000143774926004724/0001437749-26-004724-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.
Profile
| Field | Value |
|---|---|
| Ticker | PLSE on Nasdaq |
| Sector | Health Care |
| Industry | Medical/Dental Instruments |
| Country | United States |
| IPO year | 2016 |
| SEC CIK | 0001625101 |
| SEC industry code | Surgical & Medical Instruments & Apparatus |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $350K |
| Net income | -$72.8M |
| Operating income | -$76.9M |
| Net margin | -20794.6% |
| Operating margin | -21982.6% |
| Revenue growth | No prior-year revenue to compare |
| Cash | $80.7M |
| Total assets | $94.5M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 9742.1× |
Warning signs
| Sign | Finding | Source |
|---|---|---|
| Going concern | No going-concern finding. | 10-Q 2026-11-05 |
| Cash and burn | $36.7M cash; operating cash flow -$15.8M a quarter. | Report 2026-09-30 |
| Shares outstanding | 73,548,924 (2026-11-02); 67,767,578 a year earlier; 54,991,487 three years earlier. | Cover page 2026-11-02 |
| Reverse splits, 3 years | None found | None on EDGAR |
| Shelf and offerings, 12 months | 1 S-3/F-3 shelf filings; 3 424B5 takedowns, 3 at the market | Latest 2026-09-15 |
| Exchange deficiency notices, 12 months | None | None on EDGAR |
| Auditor | Deloitte & Touche LLP, San Francisco, California, United States | PCAOB Form AP 2026-02-24 |
| Late filings, 12 months | None | None on EDGAR |
| Insider trades, 12 months | Bought $13.5M, sold $3.0M on the open market | SEC Forms 3/4/5 data sets 2026-09-30 |
From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.
Quarterly results
| Quarter | Revenue | Net income | Op. cash flow | Cash | Total debt | TTM revenue | Source |
|---|---|---|---|---|---|---|---|
| Q3 2026 2026-09-30 | $395K | -$23.1M | -$15.3M | $36.7M | No debt tags | $1.5M | 10-Q 2026-11-05 |
| Q2 2026 2026-06-30 | $434K | -$24.7M | -$18.7M | $101.6M | No debt tags | $1.2M | 10-Q 2026-08-06 |
| Q1 2026 2026-03-31 | $401K | -$18.6M | -$14.6M | $68.3M | No debt tags | $751K | 10-Q 2026-05-14 |
| Q4 2025 2025-12-31 | $264K | -$17.4M | -$14.8M | $80.7M | No debt tags | $350K | 10-K 2026-02-19 |
| Q3 2025 2025-09-30 | $86K | -$19.4M | -$13.0M | $95.2M | No debt tags | $86K | 10-Q 2026-11-05 |
| Q2 2025 2025-06-30 | $0 | -$19.2M | -$12.8M | $106.3M | No debt tags | $0 | 10-Q 2026-08-06 |
| Q1 2025 2025-03-31 | $0 | -$16.8M | -$13.5M | $119.3M | No debt tags | $0 | 10-Q 2026-05-14 |
| Q4 2024 2024-12-31 | $0 | -$19.4M | -$9.1M | $118.0M | No debt tags | $0 | 10-K 2026-02-19 |
From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document FORM 424B5 | 424B5 | 2026-09-15 |
| Latest annual report FORM 10-K/A | 10-K/A | 2026-04-30 |
| Latest quarterly / interim FORM 10-Q | 10-Q | 2026-11-05 |
| Latest current report FORM 8-K | 8-K | 2026-11-06 |
| Latest proxy FORM DEF 14A | DEF 14A | 2026-05-11 |
Source: SEC EDGAR submissions feed, 642 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | -5.3% |
| 1 month | +3.9% |
| 3 months | +12.3% |
| Year to date | +267.4% |
| 1 year | +256.7% |
| From 52-week high | -13.3% |
Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Medical/Dental Instruments
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| IRTC | iRhythm Holdings Inc. | $90.83 | -1.18% | $3.1B |
| NVST | Envista Holdings Corporation | $24.03 | -1.88% | $3.9B |
| VVVV | vVARDIS Holding AG | $16.00 | -3.03% | $2.9B |
| HTFL | Heartflow Inc. | $46.86 | -3.30% | $4.1B |
| ATRC | AtriCure Inc. | $55.31 | -2.69% | $2.8B |
| STVN | Stevanato Group S.p.A. | $15.53 | -1.71% | $4.2B |
| ICUI | ICU Medical Inc. | $181.87 | +1.45% | $4.5B |
| UFPT | UFP Technologies Inc. | $298.54 | -2.14% | $2.3B |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier